Quantinno Capital Management’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
Quantinno Capital Management's PRCT Position: Q3 2026 in Review
Quantinno Capital Management increased its Procept Biorobotics (PRCT) stake by 33% in Q3 2026, buying an estimated $1.01M and bringing the position to 205,820 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1676.
Quantinno Capital Management first reported a position in PRCT in Q1 2026 and has held it in 3 quarters since. 232 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.
- Quantinno Capital Management held 205,820 shares of Procept Biorobotics worth $3.75M as of Q3 2026.
- Quantinno Capital Management bought 50,784 Procept Biorobotics shares in Q3 2026, an estimated $1.01M.
- Procept Biorobotics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #1676 holding.
- Quantinno Capital Management first reported a position in Procept Biorobotics in Q1 2026 and has held it in 3 quarters since.
- 232 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.
Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.